Quick facts
Dr. Rukmini Kumar is Founder and Chief Scientist at Vantage Research and also heads Marketing, People Supply Chain (RMG), and Corporate Services. A physicist by training (B.Sc. and M.Sc. in Physics from Madras and IIT‑Madras, Ph.D. from the University of Pittsburgh), she builds quantitative biological models that support drug R&D in diabetes, auto‑immune diseases, and cancer for clients like Eli Lilly, MSD, Genentech, and the Gates Foundation.
Publications
No publications added yet.
Research
No Research Interests added yet.
Rukmini Kumar
Founder and Chief Scientist, Vantage Research
- Rukmini Kumar obtained her Ph.D. from the University of Pittsburgh in 2004, where she developed mathematical models to understand the mechanisms of acute, systemic inflammation. She has since spent her career at the intersection of engineering and biology, as applied to drug development
- Her work has contributed to scientific publications that have informed several biopharma R&D programs in diabetes, auto-immune diseases and cancer through her roles at Immunetrics & Entelos. In 2013, Rukmini co-founded Vantage Research, to provide Pharma R&D solutions that integrate biological knowledge in a quantitative manner to solve the challenging problems in novel drug discovery and development. The Vantage Modelling & Simulation team works with leading companies such as Eli Lilly, MSD, Genentech & the Gates Foundation.
- Rukmini Kumar has a Bachelor’s in Physics (University of Madras), a Master’s in Physics (IIT-Madras) and a Ph.D. in Physics (University of Pittsburgh).
